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Introduction
Familial Mediterranean fever (FMF) is one of the most
common autoinflammatory diseases (AID). A variety of
relevant mutations in the MEFV gene have been demon-
strated. Pro-inflammatory S100 proteins correlate with
disease activity in autoinflammatory disorders, and have
been previously correlated with clinically active FMF.
Here, we describe the association between these biomar-
kers and stable FMF including different mutations, as
recorded in the German AID-Net-registry.
Objectives
Our objectives were to 1) analyse genotype-phenotype
correlations and 2) describe mutation-specific associa-
tions with associations with MRP8/14 and S100A12
biomarker results, in stable FMF patients.
Methods
We used two common scoring systems modified for chil-
dren (Mor et al., Pras et al.) to assess disease severity in
243 FMF patients of the AID-Net-registry. For the five
most frequent mutations, we tested for a correlation of the
genotype with the phenotype, mean CRP, and ethnic ori-
gin, respectively. Patients were sub-grouped by mutation
and their MRP8/14 and S100A12 biomarker results were
evaluated. Statistical significance was tested using SPSS.
Results
Among the 243 patients, we detected a total of 433 pyrin
mutations and 22 different sequence variants, including
one new mutation (p.Gly488Asp). The five most frequent
alterations were p.Met694Val (55%, n = 238), p.Met680lle
(12%, n = 52), p.Val726Ala (10%, n = 44), p.Glu148Gln
(8%, n = 34) and p.Met694Ile (2,3%, n = 10). P.Met694Val
in homozygous form (30%, n = 73) was correlated with a
more severe disease activity, based on the score by Mor, as
well as with a higher mean CRP (74 versus 31 mg/l) com-
pared to patients without this mutation (p = 0.01 and
p < 0.01, respectively). The score suggested by Pras did
not yield a significant genotype-phenotype correlation;
indeed, the two scoring systems were inconsistent with
each other (r < 0.07). Patients with any M694V gene muta-
tion did not have different MRP8/14 concentrations than
patients without M694V mutations (mean 5,830 versus
2,640 ng/ml; p = 0.88). Patients with any M694V gene
mutation did also not have different S100A12 levels (1,880
vs 495 ng/ml; p = 0.39). M694V heterozgotes also did not
differ from M694V homozygotes in either MRP8/14 or
S100A12 levels (p = 0.81 and p = 0.74, respectively).
Conclusion
The homozygous p.Met694Val substitution was asso-
ciated with a more severe disease activity. We did not
find any statistically significant differences in the MRP8/
14 or S100A12 levels between patients with and without
M694V mutations, or between M694V heterozygotes or
homozygotes in those with stable FMF. The well-known
severity scores for children (Mor, Pras) are inconsistent.
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